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ORIGINAL ARTICLE
Hirschsprung disease (HD) is the most common
cause of neonatal intestinal obstruction, and is
characterized by the absence of intramural gan-
glion cells in the nerve plexuses of the distal gut.
HD is present in neonates or early childhood, with
symptoms ranging from chronic constipation 
to acute ileus. It affects one in 5000 live new-
borns, with a male predominance (3:1 to 5:1).1
The disease has a complex genetic etiology with
susceptibility genes including members of the
RET,2–5 or endothelin (EDNRB)-regulated signal-
ing pathways,6,7 and SOX-10-mediated transcrip-
tional regulation.8
Coding sequence mutations in the receptor
tyrosine kinase gene RET, the major HD gene,
can be identified in up to 50% of familial and
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Background/Purpose: Mutations in the receptor tyrosine kinase RET gene are associated with Hirschsprung
disease (HD), which is also known as congenital intestinal aganglionosis. We found an association with
specific alleles in five single nucleotide polymorphism (SNP) sites of the RET gene in our HD patients.
Methods: We compared the association of specific RET SNP alleles in patients with severe GI disorders
such as anorectal malformation (ARM) or pediatric intestinal pseudo-obstruction (IPO) to that in HD pa-
tients. Sixty-four HD, 23 ARM and 35 IPO patients were included. Genomic DNA extracted from blood
samples was analyzed by polymerase chain reaction and DNA sequencing analysis.
Results: The allele distributions of all five RET SNPs in the HD patients deviated from those in the normal
population (p < 0.05), whereas those of the ARM patients did not. The allele distributions of these RET
SNPs in the IPO patients were all significantly different from those in the HD patients. Allele distributions
of exon 2 and 13 in the IPO patients were also significantly different from those of the normal population.
The frequencies of all the HD-predominant alleles were lower in the HD patients than the normal popu-
lation, and were even lower in the IPO patients.
Conclusion: This study strengthens the association of specific RET SNP alleles with typical HD in Taiwan.
[J Formos Med Assoc 2010;109(1):32–38]
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7–35% of sporadic cases in various populations
with different penetrance.4,5,9–14 The rate of RET
mutation in HD patients in Taiwan in our previ-
ous study was low (3.6%) compared with that
reported in other populations. Nevertheless, 
we have demonstrated the association between
HD and specific alleles in five single nucleotide
polymorphism (SNP) sites in the RET coding 
regions.15
Anorectal malformation (ARM) caused by the
absence or ectopic location of the anus is often
associated with rectal ectasia, a state of massive
dilation of the rectum and distal sigmoid colon.
The incidence is approximately 1:5000 live
births, with a male predominance. ARM can be
primary at birth, with characteristic features such
as dilated recto-sigmoid colon with a thin bowel
wall, without hypertrophy of smooth muscles, 
or rectal ectasia with balloon-like rectum,16
colonic inertia,17 megarectum,18 and pseudo-
Hirschsprung disease.19 As a result of intestinal
obstruction and sepsis, many newborn ARM pa-
tients have to be treated surgically. Some ARM
patients develop secondary rectal ectasia postop-
eratively as a result of bowel reaction to distal
obstruction, or inadequate evacuation.20 Despite
its clinical relevance, the etiology and pathogen-
esis of typical HD and ARM associated with rec-
tal ectasia are different.
Intestinal pseudo-obstruction (IPO) is a func-
tional gastrointestinal (GI) disorder with symp-
toms including cramps, stomach pain, nausea,
vomiting, bloating, fewer bowel movements than
usual, and loose stools. Pediatric IPO refers to a
heterogeneous group of disorders that are char-
acterized by intestinal obstruction in the absence
of mechanical evidence of obstruction.21 The eti-
ology of IPO can involve abnormalities of the
neurogenic or myogenic control mechanisms 
of gut motility. Although most IPO patients are
referred to as sporadic, familial forms also have
been described with either autosomal recessive or
dominant transmission.22–24 Surgery usually
plays a limited role in the treatment of IPO.
ARM and IPO patients represent a population
with severe GI disorders other than HD, which is
frequently encountered in pediatric surgery de-
partments. We thus analyzed the five RET SNP
sites of our patients to further support the non-
random association of the RET polymorphisms
in HD patients in Taiwan.
Materials and Methods
Samples
Sixty-four HD patients were diagnosed at infancy
and underwent a definite pull-through operation
at Chung Shan Medical University Hospital 
and Affiliate Hospitals from 1976 to 2005. Fifty-
two patients had short-segment aganglionosis
and 12 had long-segment aganglionosis, includ-
ing two with total colon aganglionosis. Patients
with Down syndrome or ARM were excluded
from this group. Twenty-three ARM patients and
35 functional GI disorder patients with IPO were
under medical treatment at Chung Shan Medical
University Hospital from 1999 to 2006. The
ARM patients included 14 with dilated rectal
pouch and six with Down syndrome (three 
combined with dilated rectal pouch). The IPO
patients suffered from severe constipation, but
rectal biopsies revealed the presence of ganglion
cells. There were four familial cases. Control DNA
samples were obtained from normal individuals
in Central or Southern Taiwan, who did not have
HD, ARM or IPO. The study was approved by the
local Institutional Review Board.
Polymerase chain reaction (PCR) and 
DNA sequence analysis
Genomic DNA was extracted from blood 
samples by the Puregene Genomic DNA Purifi-
cation Kit (Gentra Systems, Big Lake, MN, USA),
according to manufacturer’s instruction. PCR am-
plification of the five RET exons (2, 7, 11, 13 and
15) was performed as described previously.15 Basi-
cally, 150 ng of genomic DNA was amplified in a
50-μL reaction that contained 20 pmol each pri-
mer and 2 U Taq DNA polymerase (Gene Pure
Technology, Taichung, Taiwan). The PCR products
were purified by a PCR-M® Clean Up System
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(Viogene, Taipei, Taiwan) and subjected to auto-
mated sequencing. For some patients or controls,
polymorphisms in exons 2, 13, and 15 of the RET
gene were examined by restriction enzyme cleav-
age as described previously.15 The PCR products of
exon 2 or 15 were digested with EagI or RsaI, re-
spectively, at 37°C for 2–4 hours. The PCR prod-
ucts of exon 13 were cleaved with TaqI at 65°C for
1.5 hours. DNA fragments were then analyzed by
agarose gel electrophoresis.
Immunohistochemistry
Bowel tissue sections were obtained from a HD pa-
tient with typical rectosigmoid and an ARM pa-
tient with rectal ectasia. Immunohistochemical
studies were performed on paraffin-embedded
tissue sections. The slides were incubated at
50°C overnight, then soaked in xylene for 10
minutes for three times, and immersed in 100%
ethanol for 5 minutes, 95% ethanol for 5 min-
utes, and 80% and 70% ethanol for 1 minute
each. After rehydration for 5 minutes, the slides
were boiled in citrate buffer (pH 6.1, Target
Retrieval Solution; Dako, Carpinteria, CA, USA)
for 25 minutes, rinsed with water and 1 × PBS, and
treated with 3% hydrogen peroxide for 10 min-
utes. After that, the slides were incubated with
anti-Neuronal Nuclei (NeuN) antibodies (1:100
dilution; Chemicon, Temecula, California, USA)
at room temperature for 30 minutes and then 
biotinylated secondary antibody (Dako) for 30
minutes, and finally in a solution of streptavidin–
horseradish peroxidase (LSAB2 System; Dako)
for 30 minutes. Color was with the Substrate–
Chromogen Solution (LSAB2 System; Dako) 
for 5 minutes, and counter-stained with Mayer
hematoxylin (Merck, Darmstadt, Germany) for 1
minute. At last, the slides were dehydrated in 50%,
75% and 100% ethanol for 1 minute each, and
sealed with mounting medium (CytosealTM 60
Thermo Scientific, Waltham, MA, USA).
Statistical analysis
The χ2 test was used to determine the signifi-
cance of the association of the allele frequencies
between patients and normal control groups.
Results
RET gene polymorphisms in HD or ARM
patients
We investigated 64 typical HD patients. The al-
lele distributions of the five RET SNPs (c135G > A
in exon 2, A45A; c1296G > A in exon 7, A432A;
c2071G > A in exon 11, G691S; c2307T > G in exon
13, L769L; and c2712C > G in exon 15, S904S) 
in this HD population were very close to those 
in our previous study,15 with significant deviation
(p < 0.05) from those of the normal population
(Table 1). The frequencies of allele A of c135G > A,
allele G of c1296G > A, allele G of c2071G > A, al-
lele G of c2307T > G and allele C of c2712C > G
were significantly higher in our HD patients than
in the controls.
To investigate whether the association of RET
SNPs was specific to HD patients, we investigated
RET polymorphisms in ARM patients. No signifi-
cant differences were detected in the allele distri-
butions of these five RET SNPs between the ARM
patients and normal controls. Statistically signifi-
cant deviations (p < 0.02) were detected in the al-
lele frequencies of three RET SNPs (exons 7, 11,
and 13) between HD and ARM patients (Table 1).
RET gene polymorphism in pediatric IPO
patients
We determined the allele distributions of the RET
SNPs in patients with IPO. There were significant
differences in the allele frequencies of all five
SNPs between patients with HD and IPO (p <
0.001; Table 2). In addition, significant differences
were also detected in the frequencies of exons 
2 and 13 SNPs between the IPO patients and
normal controls (p < 0.05). The frequency of the
G allele of c135 (exon 2) in HD patients was
0.31, while the frequency increased to 0.46 and
0.61 in normal and IPO patients, respectively. For
the T variant of c2307 (exon 13), the frequency
in HD patients was 0.30, while the frequency in-
creased to 0.47 and 0.64 in normal and IPO pa-
tients, respectively. It was apparent that the G allele
of the c135 SNP and the T allele of the c2307
SNP were more frequent in the normal and IPO
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populations than that in the HD patients. Although
there are no statistically significant difference in
the other sites (exon 7, 11, and 15) among the three
groups, the frequencies of the HD-predominant
alleles showed a decrease order of HD patients >
normal population > IPO patients in exon 7
(0.97 > 0.77 > 0.71), exon 11 (0.98 > 0.91 > 0.84)
and exon 15 (0.99 > 0.92 > 0.87), respectively.
Immunohistochemistry of tissues from HD
and ARM patients
A low incidence of ARM associated with typical
HD has been reported.26,27 To confirm our clas-
sification of patients as typical HD or ARM 
patients associated with rectal ectasia, we per-
formed immunohistochemical studies. NeuN
has been used as a neuron-specific marker for the
Table 1. Allele frequencies of RET polymorphisms in Hirschsprung disease patients, anorectal malformation
patients, and normal population
Allele frequency* Statistics
Exon Codon Nucleotide HD ARM N HD vs. N ARM vs. N ARM vs. HD 
change
(128) (46) (100) χ2 p χ2 p χ2 p
2 A45A c135G > A G:0.31 0.43 0.46 5.19 0.023 0.081 0.776 2.24 0.135
A:0.69 0.57 0.54
7 A432A c1296G > A G:0.97 0.80 0.77 21.24 < 0.001 0.217 0.641 13.23 < 0.001
A:0.03 0.20 0.23
11 G691S c2071G > A G:0.98 0.89 0.91 4.98 0.026 0.127 0.772 5.61 0.018
A:0.02 0.11 0.09
13 L769L c2307T > G T:0.30 0.54 0.47 7.19 0.017 0.681 0.409 8.91 0.003
G:0.70 0.46 0.53
15 S904S c2712C > G C:0.99 0.96 0.92 7.71 0.005 0.660 0.418 2.54 0.111
G:0.01 0.04 0.08
*The numbers in the parentheses are the numbers of the alleles included in the analyses. HD = Hirschsprung disease; ARM = anorectal
malformation; N = normal population.
Table 2. Allele frequencies of RET polymorphisms in Hirschsprung disease patients, intestinal pseudo-
obstruction patients and normal population
Allele frequency* Statistics
RET Nucleotide
HD IPO N HD vs. IPO IPO vs. N
exon
Codon
change
(128) (70) (100) χ2 p χ2 p
2 A45A c135G > A G:0.31 0.61 0.46 16.92 < 0.001 3.93 < 0.050
A:0.69 0.39 0.54
7 A432A c1296G > A G:0.97 0.71 0.77 27.51 < 0.001 0.68 0.411
A:0.03 0.29 0.23
11 G691S c2071G > A G:0.98 0.84 0.91 12.31 < 0.001 1.78 0.181
A:0.02 0.16 0.09
13 L769L c2307T > G T:0.30 0.64 0.47 22.25 < 0.001 4.96 < 0.050
G:0.70 0.36 0.53
15 S904S c2712C > G C:0.99 0.87 0.92 13.76 < 0.001 1.08 0.300
G:0.01 0.13 0.08
*The numbers in the parentheses are the numbers of the alleles included in the analyses. HD = Hirschsprung disease; IPO = intestinal
pseudo-obstruction; N = normal population.
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detection of ganglion cells in colonic plexuses.28
Immunostaining results showed that mature
large ganglion cells were present in the myenteric
plexuses of the normal segments (Figure A) but
was absent in those of abnormal distal segments
in a typical HD patients (Figure B). Conversely,
NeuN immunostaining results of an ARM pa-
tient associated with rectal ectasia showed mature
large ganglion cells in the myenteric plexuses 
of normal segments (Figure C) and in those of
the abnormal segments from rectal ectasia or the
distal pouch (Figure D).
Discussion
RET coding region mutations are only found in a
small fraction of typical HD patients but the as-
sociation of variants or haplotypes has been
shown in different populations.29–32 We have re-
ported previously the association of five different
RET SNPs with typical HD in Taiwan.15 The re-
sult was very similar to that in the Chinese pop-
ulation in Hong Kong32 but different from other
Asian populations in Korea33 and Thailand.34
We further analyzed these polymorphic sites in
23 ARM patients but did not detect any signifi-
cant difference (p > 0.05) between the allele dis-
tributions of all five RET SNPs in patients and
the normal population. However, the allele dis-
tributions of exon 2 and 15 SNPs in ARM pa-
tients did not differ significantly from those in
HD patients. This was probably the result of 
the limited sample size of the ARM patients.
Neuron-specific NeuN immunohistochemical
analysis confirmed our clinical classification, and
excluded the possibility of misclassification of
the patients.
Pediatric IPO might arise from neuropathy 
or myopathy.21 IPO patients included in the 
present study were characterized by signs and
symptoms of intestinal obstruction without 
A
C D
B
Figure. NeuN immunoreactivity in tissue sections from a typical Hirschsprung disease patient and an anorectal malformation
patient associated with rectal ectasia. (A) Normal and (B) abnormal distal segments of a typical Hirschsprung disease patient.
(C) Normal and (D) abnormal rectal ectasia segments, along with the distal pouch of an anorectal malformation patient with
rectal ectasia. White arrows indicate positions of the myenteric plexuses in these sections (original magnification, 200×).
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mechanical evidence of obstruction. Conse-
quently, typical HD patients were excluded from
this group of patients. The RET SNPs in these
IPO patients and their allele distributions were
all significantly different from those in the HD
patients (p < 0.001). Besides, for these IPO pa-
tients, allele distributions at the polymorphic
sites of exons 2 and 13 were also significantly
different (p < 0.05) from those of the normal
control population. The frequencies of the HD-
predominant A allele of c135 (at exon 2) and the
G allele of c2307 (exon 13) was the highest in
IPO patients and the lowest in HD patients. Even
though the allele distributions in the other three
SNP sites did not differ significantly between
IPO patients and the normal population, the fre-
quencies of the HD-predominant alleles in these
three sites similar trends (HD patients > normal
population > IPO patients). The composition of
the 35 IPO patients was rather heterogeneous
and included three patients born to Vietnamese
mothers and one to a Korean father. Thus, the as-
sociation of specific RET alleles with our IPO pa-
tients was not because the patients were from a
subpopulation with common ancestors.
Decreased RET function caused by RET muta-
tions is associated with HD. On the contrary,
gain of function mutations in RET cause multi-
ple endocrine neoplasia type 2 or medullary thy-
roid carcinoma.35 Four SNPs in exons 2, 7, 13,
and 15 that showed a strong association with
HD in this study did not change the encoded
amino acids. Association of reduced RET protein
expression has been reported for a few variants
or haplotypes of HD.31,36 Whether the associa-
tion of HD with RET SNPs results from closely
associated functioning variants, or the SNP per se
is responsible for the reduced RET protein func-
tion is still under investigation. It has not been
reported that the RET gene is involved in IPO.
One possible explanation of the putative asso-
ciation of specific RET alleles in our IPO patients
is that variants associated with specific RET SNPs
might affect the normal RET-related signaling 
in the enteric nervous system, even though 
neuron development might not be permanently
defective as in HD. Balanced allele distribution
for normal RET protein function might be 
required for normal intestinal motility.
In summary, neither ARM nor IPO patients
showed an association of specific alleles in the RET
coding regions as in typical HD. The results
strengthen the association of specific RET SNP 
alleles with typical HD in Taiwan. Furthermore,
specific RET alleles in exon 2 and 13 SNPs appear
to be associated significantly with IPO, which 
provides a new aspect for considering the role of
RET-related signaling in regulation of enteric
movements.
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